Use of a vector comprising a nucleic acid coding for an anti-angiogenic factor for treating corneal neovascularization
OwnerMarc Abitbolinventor
Life of this patent
Estimating the term…
Abstract
The invention concerns the use of a vector comprising a nucleic acid coding for an anti-angiogenic factor for preventing, improving and/or treating corneal neovascularization.
Claims12
The use of a vector comprising a nucleic acid encoding an anti-angiogenic factor for the preparation of a pharmaceutical composition intended to be administered by impregnation of a soft lens and application of said lens on to the cornea, for the prevention, improvement and/or treatment of corneal neovascularization.
A process for preparing a medicinal product which is useful for the prevention, improvement and/or treatment of corneal neovascularization, characterized in that a recombinant vector comprising a nucleic acid encoding an anti-angiogenic factor is mixed with one or more compatible and pharmaceutically acceptable adjuvants.
A pharmaceutical composition comprising a defective recombinant vector which comprises at least one nucleic acid encoding an anti-angiogenic factor, characterized in that it is formulated for intraocular administration.
Dependencies are inferred from the claim text.